Skip to main content
Lawrence Recht, MD, Neurology, Palo Alto, CA

LawrenceDavidRechtMD

Neurology Palo Alto, CA

Neurooncology

Professor, Neurology & Neurological Sciences, Stanford University Medical Center

Dr. Recht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Recht's full profile

Already have an account?

  • Office

    875 Blake Wilbur Dr
    RM Cc2221
    Palo Alto, CA 94304
    Phone+1 650-725-8630
    Fax+1 650-498-4686

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1982 - 1984
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1979 - 1982
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1977 - 1979
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2025
  • MA State Medical License
    MA State Medical License 1984 - 2005
  • CT State Medical License
    CT State Medical License 1997 - 2001
  • MN State Medical License
    MN State Medical License 1978 - 1979
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Early Data Support Further Study of Ivosidenib in mIDH1 Glioma
    Early Data Support Further Study of Ivosidenib in mIDH1 GliomaJuly 17th, 2020
  • New Glioblastoma Trial Combines Plerixafor with Whole-Brain Irradiation
    New Glioblastoma Trial Combines Plerixafor with Whole-Brain IrradiationMay 28th, 2019

Grant Support

  • Cdon: A Novel Marker Of Neuronal Stem CellsNational Institute Of Neurological Disorders And Stroke2008
  • Clinical Trial: Peritumoral Brain Edema In Patients With Primary Malignant GliomNational Center For Research Resources2008
  • Clinical Trial: Hcrf For Patients With Malignant Brain Tumor WHO Require High-DoNational Center For Research Resources2008
  • Clinical Trial: Dexamethasone-Sparing Study Comparing (HERF) To PlaceboNational Center For Research Resources2008
  • Quantifying Cortical Neuron Production After TransplantationNational Institute Of Neurological Disorders And Stroke2007–2008
  • Spo 33555: Cdon: A Novel Marker Of Neural Stem CellsNational Institute Of Neurological Disorders And Stroke2007
  • Peritumoral Brain Edema In Patients With Primary Malignant Glioma;(Hcrf) To DEXNational Center For Research Resources2007
  • Hcrf For Patients With Malignant Brain Tumor WHO Require High-Dose DexamethasoneNational Center For Research Resources2007
  • Dexamethasone-Sparing Study Comparing Herf To PlaceboNational Center For Research Resources2007
  • Peritumoral Brain Edema In Patients With Malignant Brain TumorNational Center For Research Resources2006
  • Stem Cell Plasticity After Blastocyst ImplantationNational Institute Of Neurological Disorders And Stroke2003–2004
  • Stem Cell Plasticity After Blastocyst ImplantationNational Institute Of Neurological Disorders And Stroke2001–2002
  • Neural Stem Cells And Neuro-OncologyNational Cancer Institute2001–2002
  • Neural Stem Cells--Novel Antiglioma StrategiesNational Cancer Institute1998–2002
  • Treatment Of Glioblastomas With ImmunotoxinsNational Institute Of Neurological Disorders And Stroke1992–1996